A 6 microRNA Tool for Stratifying Stage II Colon Cancer of Receiving

Status Not yet recruiting

Clinical Trial Summary

Whether patients with stage II colon cancer should receive adjuvant chemotherapy or not is still on debate.MicroRNA(miRNA) is a promising tool. Investigators invented a tool consisting of 6 miRNA(miR-21、miR-20a-5p、miR-103a-3p、miR-106b-5p、miR-143-5p and miR-215) that was effective to identify one should accept adjuvant chemotherapy or not. Here investigators randomly assign patients to be assessed by classical pathological features or the miRNA tool of determining who should accept chemotherapy. Disease free survival and overall survival are the end points of observation.

Clinical Trial Description

Investigators randomly assign patients to be assessed by classical pathological features(control group) or the miRNA tool(experimental group). Pathological features include poorly differentiated histology(exclusive of those cancers that are MSI-H),lymphatic/vascular invasion,bowel obstruction and <12 lymph nodes examined.MicroRNA tool contains miRNA of miR-21、miR-20a-5p、miR-103a-3p、miR-106b-5p、miR-143-5p and miR-215. Investigators evaluate these miRNA status of surgical specimens using qRT-PCR and calculate their risk score(risk score =(0.108×status of miR-21-5p)+(0.086×status of miR-20a-5p)+(0.240×status of miR-103a-3p)+(0.095×status of miR-106b-5p)-(0.238×status of miR-143-5p)-(0.237×status of miR-215),low expression status equals 0 and high expression status equals 1). Investigators defined high risk patient if had any pathological features in control group or the score larger than 1 in the experimental group ,the others as low risk patient.The high risk group should receive adjuvant chemotherapy while the low risk group deserve observation. Primary endpoint is the disease free survival and overall survival. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02466113
Study type	Interventional
Source	First Affiliated Hospital, Sun Yat-Sen University
Contact	Zehong Chen, master
Phone	+8613751773229
Email	stevenchen8@qq.com
Status	Not yet recruiting
Phase	N/A
Start date	January 2016
Completion date	January 2026

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03746353` - Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer	N/A
Recruiting	`NCT05809999` - IBD Neoplasia Surveillance RCT	N/A
Recruiting	`NCT06041945` - Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology	N/A
Not yet recruiting	`NCT02688699` - Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract	Phase 4
Not yet recruiting	`NCT03175146` - A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely	N/A
Completed	`NCT02529007` - Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening	N/A
Not yet recruiting	`NCT01929499` - Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer	Phase 2
Completed	`NCT01681472` - PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer	Phase 1/Phase 2
Completed	`NCT01438645` - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy	N/A
Completed	`NCT00535652` - Concentration of Ertapenem in Colorectal Tissue	Phase 4
Terminated	`NCT00267787` - Molecular Genetic and Pathological Studies of Anal Tumors
Completed	`NCT05498051` - Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.	N/A
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT03314896` - Laparoscopic Surgery for T4 Tumor of the Colon Cancer (LST4C Trial)	N/A
Not yet recruiting	`NCT02777437` - Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer	Phase 2/Phase 3
Not yet recruiting	`NCT02852915` - Laparoscopic Surgery for T4 Tumor of the Colon Cancer	Phase 3
Completed	`NCT00997802` - Japanese National Computed Tomographic (CT) Colonography Trial	N/A
Completed	`NCT01056913` - NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery	Phase 4
Completed	`NCT00537901` - First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study	N/A
Completed	`NCT00470782` - Aerobic Capacity and Body Composition in Colon Cancer Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A 6 microRNA Tool for Stratifying Stage II Colon Cancer of Receiving Adjuvant Chemotherapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms